Immediate Impact

4 by Nobel laureates 7 from Science/Nature 80 standout
Sub-graph 1 of 22

Citing Papers

Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes
2024 Standout
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
2023 Standout
2 intermediate papers

Works of M.B. Atkins being referenced

Treatment-free survival, with and without toxicity, as a novel outcome applied to immuno-oncology agents in advanced renal cell carcinoma
2019
Survival, Response Duration, and Activity By Braf Mutation (Mt) Status in a Phase 1 Trial of Nivolumab (Anti-Pd-1, Bms-936558, Ono-4538) and Ipilimumab (Ipi) Concurrent Therapy in Advanced Melanoma (Mel)
2014

Author Peers

Author Last Decade Papers Cites
M.B. Atkins 183 155 70 84 22 357
Luis Miguel Juárez‐Salcedo 101 75 82 58 24 313
José R. Borbolla‐Escoboza 107 126 50 78 18 372
Uqba Khan 161 86 81 74 33 375
Eduardo Huertas 206 157 49 54 18 380
Gary W. Jean 230 78 77 92 14 364
Chun‐Jung Chang 132 148 65 100 15 338
Alan Koterba 75 88 119 59 21 377
Fernando Sánchez Loria 162 157 47 44 20 382
Timothy Carll 162 100 76 32 24 331
Ajay Bapna 111 61 64 74 36 321

All Works

Loading papers...

Rankless by CCL
2026